“showed a trend”

Māori or Pacific ethnicity showed a trend toward greater HbA1c reduction (coefficient = −5.62, 95% CI: −13.27 to 2.02, p = 0.148).

HPV-positive LSCC showed a trend toward a better 5-year DSS (100% vs . 84.8%, p = 0.1485) and a significant improvement in the local/regional control rate (100% vs . 75%, p = 0.0494).

Compared to the non-HSCT group, the post-allo-HSCT group showed a trend toward a lower 2-year cumulative relapse rate (25.5% vs. 64.3%, P = 0.149) (Fig. 1C ), with overall relapse rates of 21.1% (4/19) and 38.9% (7/18), respectively.

Hemoptysis positive patients showed a trend of a larger total growth of the pulmonary artery during follow up (3.82±2.77 mm vs. 2.68±2.81, p = 0.149) and a trend of a faster growth per month (0.156±0.146 vs. 0.063±0.151, p = 0.107).

Intraoperative bleeding showed a trend toward lower volumes in the WeChat remote platform group (7.61 ± 3.86 vs. 6.88 ± 3.63 ml, p = 0.149, adjusted p = 0.085), though this difference did not reach statistical significance (Table 1 ).

The data showed a trend that patients with high mGPS suffered earlier progression compared to those with low mGPS (54.3 vs 88.1 months, P = 0.149).

The five TPM cases showed a trend ( p = 0.149) for decreased/absent HDAC9 expression in the nucleus of pNEN cells.

The TAVR group showed a trend towards a higher 1-year all-cause mortality, compared with the SU-AVR group (7.0% vs 1.7%, p =0.149).

However, analysis of the clinical presentation revealed that patients under agalsidase-beta tended to be older ( p = 0.1371) and showed a trend towards a longer ERT duration ( p = 0.1499) than patients receiving agalsidase-alfa (Additional file 3 : Table S3).

study demonstrated that the HPV-positive LSCC showed a trend towards a better 5-year survival (100% & 85%; p = 0.15) and a significant improvement in the local/regional control rate (100% & 75%; p = 0.05), comparing to HPV-negative.

In the meantime, hemiparkinsonian rats treated with intranasal SP-GNP (p = 0.001) and intravenous SP-GNP (p = 0.02) showed a significant decrease on apomorphine-induced rotation than hemiparkinsonian rats with intranasal PBS solution treatment, while those with intranasal SP solution and blank GNP treatment showed a trend of improvement without statistical significance (p = 0.15 and p = 0.35 respectively).

Regression analysis showed a trend to decreased sample sizes from 1990 to 2020 (β = –3.8 [95% CI, 1.4 to –9.0]; P = .15).

+2.2 kg, P < 0.05) and the Orlistat group also showed a trend for better glycemic control (HbA1c -0.1% vs. +0.2%, P = 0.15), but both sub-groups showed the same reversal of plasma cholesterols and plasma triglyceride towards pre-VLCD levels (data not shown).

The MED12 IP/Input ratio showed a trend of reduction (Fig. 4F ; p = 0.15), suggesting a potential weakening of the MED1-MED12 interaction following Med13l KO.

However, the TWEAK administered mice showed a trend towards decreased forelimb grip strength (p = 0.15) and treadmill run fitness (p = 0.11) at 2 weeks ( Fig 3A and 3B ).

Construction of a DNA Repair Pathway–Focused Score Kaplan–Meier log-rank P values were calculated to identify a subset of genes whose expression values showed a trend associated with overall survival (OS) ( P < .15) ( Supplementary Figure 1 , available online).

Interestingly, α 1 increased significantly for dP2 and showed a trend to increase ( p < 0.15) for dP1 while its increase was far from the statistical threshold for the reference RRI ( p = 0.69).

Moreover, the TGF-β1-TG mice showed a trend toward higher fibronectin (FBN) mRNA expression in the ventricular tissue compared to the WT animals ( p = 0.15) ( Figure 2 D).

This was not the case for ANGPTL4 and ApoC3, although in the case of ApoC3 the multivariable analysis showed a trend to be significant (beta coef. 0.7 [95%CI -0.3-0.17] mg/dl, p=0.15) ( Table 5 ).

23%; P = 0.032) and stent implantation showed a trend towards higher rates (66% vs. 78%; P = 0.150) in the ‘contemporary cohort’.

With respect to severe fibrosis, although serrated histology showed a trend toward lower rates of severe fibrosis, this association did not reach statistical significance in the multivariate analysis (OR: 0.49, 95% CI: 0.16–1.20, p = 0.15), likely due to the limited number of CSL cases presenting severe fibrosis in our cohort.

Although the data only showed a trend towards a reduction ( p = 0.15), the blockade of NfL increase is further confirmed by the lack of difference between 2-month-old controls and the 5-month-old S1D12 mice.

However, in our multivariate analysis, even though comorbidity was not an independent predictive factor for AEs, cardiovascular disease showed a trend toward risk complications ( P = 0.15).

In multivariable analysis, larger LA diameter showed a trend toward an increased risk of new-onset AF (OR 1.10 per mm, 95% CI 0.97–1.25, p = 0.15) among patients without previous AF, whereas sex, age, common risk factors, or cardiomyopathy were not significant predictors.

Statistical comparison of the correlation coefficient observed at baseline to that observed post stimulation showed a trend level decrease in correlation between these two time periods (Fischer’s z transform: z = 1.04, p = 0.15).